Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mindsets, informed consent, and research.

Literature DB >> 24375292

Mindsets, informed consent, and research.

Abstract

Study after study shows that subjects regularly overestimate the likelihood of gaining therapeutic benefit from a clinical trial. But more study is needed on why that mistake is common, and what it says about informed consent. Subjects may think about research differently at different phases in their participation.

Entities: Disease Gene Species

Mesh：

Year: 2013 PMID： 24375292 PMCID： PMC3985429 DOI： 10.1002/hast.237

Source DB: PubMed Journal: Hastings Cent Rep ISSN： 0093-0334 Impact factor: 2.683

13 in total

1. Therapeutic misconception and the appreciation of risks in clinical trials.

Authors: Charles W Lidz; Paul S Appelbaum; Thomas Grisso; Michelle Renaud
Journal: Soc Sci Med Date: 2004-05 Impact factor: 4.634

2. Maintaining informed consent validity during lengthy research protocols.

Authors: Kristen J Prentice; Paul S Appelbaum; Robert R Conley; William T Carpenter
Journal: IRB Date: 2007 Nov-Dec

3. Two models of implementing informed consent.

Authors: C W Lidz; P S Appelbaum; A Meisel
Journal: Arch Intern Med Date: 1988-06

4. The therapeutic misconception: informed consent in psychiatric research.

Authors: P S Appelbaum; L H Roth; C Lidz
Journal: Int J Law Psychiatry Date: 1982

5. Unrealistic optimism in early-phase oncology trials.

Authors: Lynn A Jansen; Paul S Appelbaum; William M P Klein; Neil D Weinstein; William Cook; Jessica S Fogel; Daniel P Sulmasy
Journal: IRB Date: 2011 Jan-Feb

6. Research participants' high expectations of benefit in early-phase oncology trials: are we asking the right question?

Authors: Kevin P Weinfurt; Damon M Seils; Li Lin; Daniel P Sulmasy; Alan B Astrow; Herbert I Hurwitz; Roger B Cohen; Neal J Meropol
Journal: J Clin Oncol Date: 2012-10-22 Impact factor: 44.544

7. The effects of mindset on behavior: self-regulation in deliberative and implemental frames of mind.

Authors: David A Armor; Shelley E Taylor
Journal: Pers Soc Psychol Bull Date: 2003-01

8. Ethics of phase 1 oncology studies: reexamining the arguments and data.

Authors: Manish Agrawal; Ezekiel J Emanuel
Journal: JAMA Date: 2003-08-27 Impact factor: 56.272

9. Perceptions of cancer patients and their physicians involved in phase I trials.

Authors: C Daugherty; M J Ratain; E Grochowski; C Stocking; E Kodish; R Mick; M Siegler
Journal: J Clin Oncol Date: 1995-05 Impact factor: 44.544

10. Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option?

Authors: Franklin G Miller; Steven Joffe
Journal: Clin Trials Date: 2008 Impact factor: 2.486

8 in total

1. Motivations and Decision Making Processes of Men With X-linked Retinoschisis Considering Participation in an Ocular Gene Therapy Trial.

Authors: Amy Turriff; Delphine Blain; Morgan Similuk; Barbara Biesecker; Henry Wiley; Catherine Cukras; Paul A Sieving
Journal: Am J Ophthalmol Date: 2019-03-16 Impact factor: 5.258

2. Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials.

Authors: Sarah B Garrett; Thea M Matthews; Corey M Abramson; Christopher J Koenig; Fay J Hlubocky; Christopher K Daugherty; Pamela N Munster; Daniel Dohan
Journal: JCO Oncol Pract Date: 2019-10-11

Mindsets, informed consent, and research.

1. Therapeutic misconception and the appreciation of risks in clinical trials.

2. Maintaining informed consent validity during lengthy research protocols.

3. Two models of implementing informed consent.

4. The therapeutic misconception: informed consent in psychiatric research.

5. Unrealistic optimism in early-phase oncology trials.

6. Research participants' high expectations of benefit in early-phase oncology trials: are we asking the right question?

7. The effects of mindset on behavior: self-regulation in deliberative and implemental frames of mind.

8. Ethics of phase 1 oncology studies: reexamining the arguments and data.

9. Perceptions of cancer patients and their physicians involved in phase I trials.

10. Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option?

1. Motivations and Decision Making Processes of Men With X-linked Retinoschisis Considering Participation in an Ocular Gene Therapy Trial.

2. Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials.

3. Variations in Unrealistic Optimism Between Acceptors and Decliners of Early Phase Cancer Trials.

4. Cancer clinical trial participants' assessment of risk and benefit.

5. "Watching time tick by…": Decision making for Duchenne muscular dystrophy trials.

6. What motivates participation in HIV cure trials? A call for real-time assessment to improve informed consent.

Review 7. The sociology of cancer: a decade of research.

8. Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial.